این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Basic Medical Sciences، جلد ۲۵، شماره ۱۲، صفحات ۱۴۴۲-۱۴۵۱
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی In vivo study of anticancer activity of ginsenoside Rh2-containing arginine-reduced graphene in a mouse model of breast cancer
چکیده انگلیسی مقاله Objective(s): This study aims to evaluate the in vivo anticancer activity of arginine-reduced graphene (Gr-Arg) and ginsenoside Rh2-containing arginine-reduced graphene (Gr-Arg-Rh2). Materials and Methods: Thirty-two mice with breast cancer were divided into four groups and treated every three days for 32 days: Group 1, PBS, Group 2, Rh2, Group 3, Gr-Arg, and Group 4, Gr-Arg-Rh2. The tumor size and weight, gene expression (IL10, INF-γ, TGFβ, and FOXP3), and pathological properties of the tumor and normal tissues were assessed. Results: Results showed a significant decrease in TGFβ expression for all drug treatment groups compared with the controls (P=0.04). There was no significant difference among the groups regarding IL10 and FOXP3 gene expression profiles (P>0.05). Gr-Arg-Rh2 significantly inhibited tumor growth (size and weight) compared with Rh2 and control groups. The highest survival rate and the highest percentage of tumor necrosis (87.5%) belonged to the Gr-Arg-Rh2 group. Lungs showed metastasis in the control group. No metastasis was observed in the Gr-Arg-Rh2 group. Gr-Arg-Rh2 showed partial degeneration of hepatocytes and acute cell infiltration in the portal spaces and around the central vein. The Gr-Arg group experienced a moderate infiltration of acute cells into the port spaces and around the central vein. The Rh2 group also showed a mild infiltration of acute and chronic cells in portal spaces. Conclusion: Based on the results, Gr-Arg-Rh2 can reduce tumor size, weight, and growth, TGF-β gene expression, and increase tumor necrosis and survival time in mice with cancer. 
کلیدواژه‌های انگلیسی مقاله Arginine, Breast Cancer, Genes, Ginsenoside Rh2, Graphene, Tumor
نویسندگان مقاله | Shervindokht Farhangfar
Department of Biology, Science and Arts University, Yazd, Iran|Reproductive Immunology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran


| Farzaneh Fesahat
Reproductive Immunology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran


| Hadi Zare-Zardini
Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran|Department of Biomedical Engineering, Meybod University, Meybod, Iran


| Mahdi Dehghan-Manshadi
Reproductive Immunology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran


| Fateme Zare
Reproductive Immunology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran


| Seyed Mohsen Mirsmaeili
Department of Biology, Science and Arts University, Yazd, Iran


| Maryam Vajihinejad
Department of Pathology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran


| Hossein Soltaninejad
Faculty of Interdisciplinary Science and Technology, Tarbiat Modares University, Tehran, Iran
نشانی اینترنتی https://ijbms.mums.ac.ir/article_21217.html
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Article
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات